TSH) 0.11 mU/L (0.35 to 5.5), free triiodothyronine (T3) 5.2 (3.5 to 6.5), free thyroxine (T4) 18 (11 to 23), and thyroglobulin 25.5 (< 43). Other routine blood tests and computed tomography imaging of her head were normal. Given the suppressed TSH, she was diagnosed with borderline hyperthyroidism.
While in hospital, the patient received olanzapine dissolvable 5 to 7.5 mg once daily, and her manic symptoms abated over a week-long hospital stay. After discharge, she did not continue taking medications. On follow-up a month later, the patient had resumed her usual activities and was euthymic. At this time, lab tests were done and showed a normal thyroid profile.
In the case of borderline hyperthyroidism, it may be difficult to establish whether the hyperthyroid state is the etiologic cause, a contributing factor to the manic episode, or simply comorbid with BD. In this case, it is reasonable to postulate that the hyperthyroid state contributed to the manic episode or precipitated a manic episode in a patient predisposed to BD. This is further supported by the fact that the patient's symptoms resolved without further medications and were coincident with normalization of her thyroid profile. This reinforces the concept that perturbations in the thyroid function may be tied to manic symptomatology. At this time, the patient's preliminary diagnosis is secondary mania, and longitudinal follow-up of her mood symptoms and thyroid function may lead to a more definitive diagnosis. If she had another manic episode without clinical or laboratory indicators of hyperthyroidism, primary BD would be the diagnosis. Notwithstanding the diagnostic dilemma, we suggest that monitoring TSH is appropriate for patients with BD. For patients with recurrent or poorly controlled manic symptoms, it may be informative to see whether the manic symptoms coincide with changes in thyroid function. In conclusion, this case underscores the importance of monitoring TSH in patients with manic episodes.
Dyslipidaemia and Psychiatric Patients
Dear Editor: Associations between atypical antipsychotics (ATPs), weight gain (1), and diabetes (2) have been reported, and links between some ATPs and dyslipidaemia, particularly elevated triglycerides, have been identified (3). Dyslipidaemia is a major contributor to cardiovascular disease and 36% of deaths (over 78 900) in Canada yearly are due to diseases of the circulatory system (4). Raised C-reactive protein is also seen as a strong predictor of a cardiovascular event (5) .
Nine months ago, I began routinely testing patients' lipid, C-reactive protein, and blood glucose levels. So far, I have tested 89 patients, about one-sixth of my practice. Among those patients tested, 67% had a two-fold or more risk of a cardiovascular event, based on a raised total cholesterol/HDL-C ratio. This held true whether the patient was on a conventional antipsychotic, (11 of 13 or 85%) , an ATP (25 of 41or 61%, or no antipsychotic (25 of 35 or 66%). Elevated C-reactive protein was present in 8% of patients. The screening process did not allow for any attribution of cause or determination of how long the elevated levels had been present.
Monitoring weight, blood glucose, and lipids should become routine psychiatric practice, and where necessary, the primary physician should be alerted. These measures are not routinely done in psychiatric inpatient settings, and a recent survey found that only about 50% of inpatients were checked for blood glucose and weight (6) . Encouraging healthy diets, weight loss, and exercise is necessary. However, results of exercise programs may not be encouraging, as motivation is crucial (7) . Medical management, including the use of statins, may be indicated.
If my results are characteristic of a general adult psychiatric population, all patients, regardless of diagnosis and treatment, should be appropriately screened and monitored. Psychiatric populations, for various reasons, appear to be at increased risk of cardiovascular disease.
Robin Menzies, MB, BS, MRCPsych, FRCPC Saskatoon, Saskatchewan

Dream Contents in Patients With Major Depressive Disorder
Dear Editor: The ancients attributed great importance to dreams. Special temples built by the ancient Chinese, Egyptians, Greeks, and Romans were sanctuaries to which people retreated to understand the meaning of their dreams. Hippocrates (469-399 BC) and Galen (ca 130 AD) believed dreams could have psychological and diagnostic utility (1) . Dreaming is one of the interesting aspects of human beings, and physicians could find important information about their patients by exploring their dreams. Dreaming also has several psychological functions, one of which is mood regulation, in healthy subjects (2) .
We observed that many of our patients with depression remembered repetitive dreams that were exhausting or frightening. In this case-controlled study, we examined the dream contents of 41 patients who met DSM-IV criteria for major depressive disorder (MDD) and 82 matched healthy subjects. We conducted the study at the Kerman psychiatric hospital in Iran. Subjects were requested to freely remember their recurrent dreams in the previous 2 months. Each dream that received at least a point 4 from Schredl's dream questionnaire, was considered a recurrent dream (3) . We organized dream contents into 14 main categories, using the Hall/Van de Castle major categories (4).
Results
The mean (SD) age of patients was 32.77 (7.83) years; 24 (58.54%) were women and 17 (46.41%) were men. Forty (97.6%) patients and 68 (82.9%) healthy subjects had at least one recurrent dream in the previous 2 months (odds ratio [OR] 68; 95%CI, 10.25 to 13.20; P = 0.02). In 40 (97.6%) patients and 10 (12.2%) control subjects, the recurrent dreams were frightening (OR 10, 95%CI, 1.33 to 208.92; P = 0.015).
Frequency distribution of dream content categories among patients with depression was as follows: death (87.80%), separation (70.73%), frightening animals (60.97%), frightening situations (58.53%), natural disasters (59.09%), aggression (48.78%), falling (43.90%), waste matters (43.90%), blood (41.49%), negative emotions (41.46%), bizarre elements (39.02%), punishment (26.83%), suicide and homicide (24.39%), and sexual harm (21.95%). All categories of dream content were more prevalent among patients with depression than among the control group.
Conclusion
In this study, we observed that many patients with depression whose chief complaint was not disturbing dreams had recurring and frightening dreams, when asked directly.
Exploring dream contents in patients with depression may be important from clinical points of view. For example, Agargun and others showed an association between repetitive and frightening dreams and suicidal tendency (5) . Diminishing frequency or even disappearance of recurrent dreams in patients with MDD show the effectiveness of treatment with antidepressants (6) . We recommend that physicians pay more attention to dream contents in patients with MDD, because these themes are unpleasant for patients, and trying to reduce them could help patients' improvement.
Alireza Ghaffari Nejad, MD; Rahyl Zahra Sanatinia, MD; Kiarash Yousofi, MD, Kerman, Iran
Sensory Deprivation and Disorders of Perception
Dear Editor: Disorders of perceptions can be seen in schizophrenia, mania, delirium, metabolic and endocrinal disorders, epilepsy, brain tumors and drug intoxication, or by direct effects of some drugs (for example, hallucinogens). They can also be seen in the electrical stimulus of structures such as the amygdale and temporal cortex and in other pathologies of the brain (1) . Perceptual disorders can also be observed, except for brain pathology or psychopathology. In these cases, it is largely suggested that the reason for perceptual disorders is sensory deprivation. Even though the mechanism is not well known, it is believed to be similar to phantom extremity phenomenon (2).
In the literature, there are articles about visual hallucinations observed in patients having visual defects without suffering from any psychiatric disorder (2) (3) (4) (5) (6) . This was first claimed by Charles Bonnet, a Swiss scientist. Bonnet's grandfather experienced live visual hallucinations at age 89 years, 11 years after having cataract surgery (3). Interestingly, Bonnet himself suffered from visual defects and afterward had similar symptoms. Morisier first named this Charles Bonnet Syndrome (CBS) in 1938 (4) . Once the syndrome was named, many similar cases were reported, and diagnostic criteria were developed for CBS (5, 6) . In this article, we report on the case of a patient with auditory hallucinations in the left ear only. The patient has suffered from hearing loss in the left ear for 5 years, but has not used a hearing and for the last 2 years.
Case Report
A woman, aged 63 years, complained that she was hearing voices for the past 1½ to 2 years and that the voices had increased in the last month, especially at night. At first, she was afraid of the voices and thought she was mad; then she realized they were not real. She had hearing loss in her left ear following a car accident 5 years ago, and it was recommended that she use a hearing aid. Since the aid disturbed her ear, she used it irregularly for 3 years and not at all thereafter. Five to 6 months later, she started to hear voices. Everything was normal in the patient's psychiatric examination except for auditory hallucinations and anxious mood. There was no substance use or psychiatric illness in her history. Complete blood count, biochemical tests, thyroid function test, EEG, cranial computed tomography scan, and neurological examinations of the patient were normal. Her score on the Mini-Mental State Exam was 27. The Minnesota Multiphasic Personality Inventory and Beier Sentence Completion tests were evaluated as normal. Treatment was started with olanzapine 10 mg daily and diazepam 10 mg daily. Later, diazepam was stopped and continued by olanzapine 5 mg daily only. On the tenth day of treatment, the auditory hallucinations disappeared. The patient was observed for 10 months at regular intervals; she took olanzapine 5 mg daily and used a hearing aid for 7 months. During this time, no psychopathology had been detected.
How could sensory deprivation cause disorders of perception? Even though the mechanism is not well known, it is believed to work similarly to phantom extremity phenomenon. In phantom extremity phenomenon, the sensory deprivation could be due to amputation of a body part, damage of the sensory nerve, brachial plexus, or blockage of the spinal cord by anesthetic agent (2) . In this case report, the sensory deprivation now caused by damage to the auditory ways after an accident. In both cases, the stimuli going to the cortex were blocked. However, how the perceptual disorders occur is still not known. Perhaps the hallucinations are due to receptor hypersensitivity. This could be explained by examining the effective mechanisms of hallucinogens and aty pical antipsy chotics. Hallucinogens and serotonin-dopamine antagonists (SDAs) act through the same receptors but create different effects. Hallucinogens activate 5HT 2A , 5HT 2C , and 5HT 6
